((自动化翻译由路透提供，请见免责声明 ))
10月8日 - ** 富国银行给予牙科产品公司 Envista Holdings "等权重 "评级，目标价 20 美元。
** 券商预计通胀环境将影响牙科植入物需求，因为患者需要自付大量费用
** NVST 的表现低于牙科市场；未来 12 个月该股跑赢大盘的机会有限--富国银行
** 13家券商中有3家将该股评为 "买入 "或更高评级，9家为 "持有"，1家为 "卖出"；其PT中值为18.50美元--LSEG数据
** 包括本交易日的走势在内，该股今年累计下跌约 24
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.